Anu Saji
Worcester, MANPI 1558932970
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.0% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,427, more than ten times the $120 reported in 2021.
Across 156 payments — averaging $29.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$674
- Amgen$518
- E.r. Squibb & Sons, L.L.C.$406
- Abbott$372
- Boehringer Ingelheim$359
- AstraZeneca$301
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,33293%
- Education$3247%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 12 | $674 |
| Amgen | 19 | $518 |
| E.r. Squibb & Sons, L.L.C. | 17 | $406 |
| Abbott | 2 | $372 |
| Boehringer Ingelheim | 17 | $359 |
| AstraZeneca(2 entities) | 15 | $301 |
| Shockwave Medical, Inc | 2 | $197 |
| Pfizer | 8 | $187 |
| Bayer | 5 | $175 |
| Esperion Therapeutics, Inc. | 19 | $171 |
| Actelion Pharmaceuticals US, Inc. | 3 | $164 |
| Heartflow, Inc. | 1 | $147 |
| Alnylam Pharmaceuticals Inc. | 2 | $109 |
| Novartis | 6 | $99 |
| Lexicon Pharmaceuticals, Inc. | 1 | $82 |
| Lantheus Medical Imaging, Inc. | 3 | $78 |
| Gilead | 1 | $76 |
| Penumbra, Inc. | 2 | $71 |
| Boston Scientific | 3 | $70 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $70 |
| Medtronic | 2 | $69 |
| Novo Nordisk | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| AbbVie | 2 | $45 |
| Scpharmaceuticals Inc. | 2 | $44 |
| Viiv Healthcare Company | 1 | $32 |
| Bridgebio Pharma, Inc. | 2 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE$268
- FFRct$147
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$141
- Repatha$122
- UPTRAVI$115
- OPSUMIT$115
- CARDIOMEMS$104
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.